annual cash & cash equivalents:
$219.87M+$34.79M(+18.79%)Summary
- As of today (August 20, 2025), RNA annual cash & cash equivalents is $219.87 million, with the most recent change of +$34.79 million (+18.79%) on December 31, 2024.
- During the last 3 years, RNA annual cash & cash equivalents has fallen by -$100.58 million (-31.39%).
- RNA annual cash & cash equivalents is now -35.41% below its all-time high of $340.40 million, reached on December 31, 2022.
Performance
RNA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$1.18B-$196.73M(-14.26%)Summary
- As of today (August 20, 2025), RNA quarterly cash & cash equivalents is $1.18 billion, with the most recent change of -$196.73 million (-14.26%) on June 1, 2025.
- Over the past year, RNA quarterly cash & cash equivalents has dropped by -$115.90 million (-8.92%).
- RNA quarterly cash & cash equivalents is now -25.52% below its all-time high of $1.59 billion, reached on September 30, 2024.
Performance
RNA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RNA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.8% | -8.9% |
| 3 y3 years | -31.4% | +197.1% |
| 5 y5 years | +132.5% | +235.7% |
RNA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.4% | +18.8% | -25.5% | +197.1% |
| 5 y | 5-year | -35.4% | +132.5% | -25.5% | +323.4% |
| alltime | all time | -35.4% | +7015.5% | -25.5% | +1233.1% |
RNA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $1.18B(-14.3%) |
| Mar 2025 | - | $1.38B(-8.1%) |
| Dec 2024 | $219.87M(+18.8%) | $1.50B(-5.5%) |
| Sep 2024 | - | $1.59B(+22.3%) |
| Jun 2024 | - | $1.30B(+41.8%) |
| Mar 2024 | - | $915.87M(+53.8%) |
| Dec 2023 | $185.08M(-45.6%) | $595.35M(+9.7%) |
| Sep 2023 | - | $542.58M(-5.9%) |
| Jun 2023 | - | $576.50M(-1.7%) |
| Mar 2023 | - | $586.30M(-4.0%) |
| Dec 2022 | $340.40M | $610.73M(+50.6%) |
| Sep 2022 | - | $405.55M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $398.22M(+0.3%) |
| Mar 2022 | - | $397.07M(-2.1%) |
| Dec 2021 | $320.45M(-0.3%) | $405.54M(-1.8%) |
| Sep 2021 | - | $413.03M(+47.8%) |
| Jun 2021 | - | $279.46M(-9.2%) |
| Mar 2021 | - | $307.91M(-6.2%) |
| Dec 2020 | $321.46M(+239.9%) | $328.14M(-3.8%) |
| Sep 2020 | - | $341.14M(-3.2%) |
| Jun 2020 | - | $352.45M(+297.1%) |
| Mar 2020 | - | $88.75M(-6.2%) |
| Dec 2019 | $94.58M(+2960.8%) | $94.58M |
| Dec 2018 | $3.09M | - |
FAQ
- What is Avidity Biosciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Avidity Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Avidity Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RNA is $219.87M
What is the all time high annual cash & cash equivalents for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual cash & cash equivalents is $340.40M
What is Avidity Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RNA annual cash & cash equivalents has changed by +$34.79M (+18.79%)
What is Avidity Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RNA is $1.18B
What is the all time high quarterly cash & cash equivalents for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly cash & cash equivalents is $1.59B
What is Avidity Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RNA quarterly cash & cash equivalents has changed by -$115.90M (-8.92%)